Harvard Bioscience
HBIO
84 hedge funds and large institutions have $87.8M invested in Harvard Bioscience in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 6 closing their positions.
0% more funds holding
Funds holding: 84 → 84 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
6% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 31
32% less capital invested
Capital invested by funds: $129M → $87.8M (-$41.2M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $36K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$3.42M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$1.28M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$1.12M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$921K |
| 5 |
Goldman Sachs
New York
|
+$816K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.14M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.77M |
| 3 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$1.26M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$769K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$614K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
UBS Group
Zurich,
Switzerland
| $7K | – | – | – |
|
77
Group One Trading
Chicago,
Illinois
| $4K | – | – | – |
|
78
Morgan Stanley
New York
| $2K | -$45.3K | -973 | -94% |
|
79
Bank of America
Charlotte,
North Carolina
| $2K | -$6.75K | -145 | -72% |
|
80
Citigroup
New York
| $2K | -$1.26K | -27 | -40% |
|
81
Barclays
London,
United Kingdom
| $1K | -$2.14K | -46 | -72% |
|
|
LTFS
82
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
83
Bessemer Group
Woodbridge,
New Jersey
| $1K | +$1.44K | +31 | New |
|
84
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $81 | -$31.8K | -683 | -24% |
|
|
GIP
85
Granite Investment Partners
El Segundo,
California
| – | -$1.26M | -22,119 | Closed |
|
|
TC
86
TFS Capital
West Chester,
Pennsylvania
| – | -$562K | -9,865 | Closed |
|
|
SIM
87
Spark Investment Management
New York
| – | -$215K | -3,790 | Closed |
|
|
MA
88
MUFG Americas
New York
| – | -$20K | -355 | Closed |
|
89
Invesco
Atlanta,
Georgia
| – | -$6K | -104 | Closed |
|
90
SEI Investments
Oaks,
Pennsylvania
| – | -$1K | -17 | Closed |
|
HBIO Hedge Fund Activity: Q3 2015 in Review
84 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q3 2015, worth a combined $87.8M — down 32% from $129M a quarter earlier.
Fund positioning in HBIO was balanced in Q3 2015: 6 funds opened new positions, 6 closed out, 29 added to existing stakes and 31 trimmed.
The largest buyer was Polar Asset Management Partners, adding an estimated $3.42M. The largest seller was Fidelity Investments, cutting an estimated $2.14M.
- 84 institutional investors held Harvard Bioscience (HBIO) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $87.8M of Harvard Bioscience stock for Q3 2015, down 32% quarter-over-quarter.
- 6 funds opened new Harvard Bioscience positions in Q3 2015 and 6 closed out, a net change of 0 holders.
- The largest Harvard Bioscience buyer in Q3 2015 was Polar Asset Management Partners, an estimated $3.42M added.
- The largest Harvard Bioscience seller in Q3 2015 was Fidelity Investments, an estimated $2.14M sold.
Based on aggregated 13F filings for Q3 2015.